New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

XLVIvsBBHETF Comparison

ETF 1
XLVI

The Health Care Select Sector SPDR Premium Income Fund

This fund is part of
Options Strategies
-0.04%
Full XLVI fund page
VS
ETF 2
BBH

VanEck Biotech ETF

This fund is part of
US Health Care
-0.31%
Full BBH fund page

The Health Care Select Sector SPDR Premium Income Fund (XLVI) belongs to the Options Strategies segment. VanEck Biotech ETF (BBH) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. Both XLVI and BBH have the same Total Expense Ratio (TER) of 0.35%. XLVI is up 0.28% year-to-date (YTD) with +$2M in YTD flows. BBH performs better with 1.49% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of XLVI and BBH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XLVI vs BBH performance and flow charts

Performance

-3.0-2.0-1.00.01.02.0%Feb 11Feb 19Feb 26Mar 5

Cumulative Flows

-2 M-1.5 M-1 M-0.5 M0 M0.5 MFeb 11Feb 19Feb 26Mar 5

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/11/2026
1M3MYTD1Y3Y5Y
Perf.
XLVI
BBH
-1.07%-1.90%
+1.89%+0.58%
+0.28%+1.49%
n/a+19.17%
n/a+25.33%
n/a+12.69%
Flows
XLVI
BBH
+$788K-$2M
+$3M-$2M
+$2M-$2M
--$58M
--$190M
--$121M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XLVI
BBH
+10.15%+19.85%
n/a+22.37%
n/a+18.42%
n/a+21.47%
Max drawdown
XLVI
BBH
-3.26%-6.07%
n/a-14.98%
n/a-22.78%
n/a-39.88%
Max drawdown duration
XLVI
BBH
10d43d
n/a128d
n/a440d
n/a1675d
Trading data

Create an account to view trading data

Join for free
XLVI
BBH
Last sale
3/11/2026 at 7:59 PM
$25.92
$188.44
Previous close
03/11/2026
$25.98
$192.04
Consolidated volume
03/11/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

XLVI
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
XLVI
BBH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/11/2026 at 7:59 PM
Live
Closed
XLVI
BBH
Last price
$25.92
$188.44
1D performance
-0.23%
-1.87%
AuM$13.24 M$379.50 M
E/R0.35%0.35%
Characteristics
XLVI
BBH
Management strategyActivePassive
ProviderSPDRVanEck
Benchmark-MVIS US Listed Biotech 25 Index
N° of holdings5722
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateJuly 30, 2025December 20, 2011
ESGNoNo
Advertisement
Exposure

Countries

XLVI
USA
96.37%
Other
3.63%
BBH
USA
96.22%
Other
3.78%

Sectors

XLVI
Health Care
97.65%
Other
2.35%
BBH
Health Care
89.47%
Other
10.53%
Advertisement

Diversification

XLVI

Total weight of top 15 holdings out of 15

69.69%
BBH

Total weight of top 15 holdings out of 15

84.43%

Top 15 holdings

Data as of January 31, 2026
XLVI
LILLY
14.60%
JOHNSON&JOHNSON
9.71%
ABBVIE
6.99%
MERCK & CO INC
4.85%
UNITEDHEALTH GRP
4.61%
THERMO FISHER SCIENTIFIC
3.85%
ABBOTT LABS
3.37%
AMGEN-T
3.26%
INTUITIVE SURGICAL
3.17%
GILEAD SCIENCES
3.12%
PFIZER
2.66%
BOSTON SCIENTIFIC
2.46%
DANAHER
2.44%
MEDTRONIC PLC
2.34%
STRYKER
2.25%
BBH
GILEAD SCIENCES
15.62%
AMGEN-T
15.10%
VERTEX PHARMACEUTICALS
9.14%
REGENERON PHARMACEUTICALS
7.18%
IQVIA HOLDINGS INC
4.54%
US04016X1019
4.53%
NATERA
4.13%
ALNYLAM PHARMACEUTICALS
3.69%
INSMED
3.57%
US07725L1026
3.50%
BIOGEN INC
3.02%
ILLUMINA
2.85%
UTD THERAPEUT
2.74%
MODERNA INC
2.41%
ICON PLC
2.40%
Frequently asked questions about XLVI and BBH

How have the XLVI and BBH ETFs performed in 2026?

As of March 11, 2026, XLVI is up 0.28% year-to-date (YTD), while BBH has returned 1.49%. That puts BBH better performer ahead so far this year.

Which ETF is attracting more investor money: XLVI or BBH?

Year-to-date, the XLVI ETF saw +$2M in flows, compared to -$2M for BBH.

Which ETF is bigger: XLVI or BBH?

As of March 11, 2026, XLVI holds $13.24 M in assets under management (AUM), while BBH manages $379.50 M.

What sectors do the XLVI and BBH ETFs invest in?

XLVI leans toward sectors like Health Care. Meanwhile, BBH focuses on Health Care.

What are the top holdings of the XLVI ETF and BBH ETF?

XLVI top holdings include LILLY, JOHNSON&JOHNSON and ABBVIE. BBH holds in its top three: GILEAD SCIENCES, AMGEN-T and VERTEX PHARMACEUTICALS.

Which ETF is more diversified: XLVI or BBH?

XLVI holds 60 securities with 69.69% of its assets in the top 15. BBH has 25 securities and a top 15 weight of 84.43%.

Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast